Among the putatively ERα-regulated intergenic lncRNAs, we identified NEAT1 as the most significantly overexpressed lncRNA in prostate cancer versus benign prostate in our patient cohort (73 samples) (Fig. 1f and Supplementary Dataset 2). This evidence concerns the gene NEAT1 and prostate cancer.